A new trading day began on Monday, with CorMedix Inc (NASDAQ: CRMD) stock price down -3.99% from the previous day of trading, before settling in for the closing price of $10.27. CRMD’s price has ranged from $2.89 to $13.85 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -50.37% over the past five years. Meanwhile, its annual earnings per share averaged 54.95%. With a float of $59.25 million, this company’s outstanding shares have now reached $60.68 million.
Let’s look at the performance matrix of the company that is accounted for 82 employees. In terms of profitability, gross margin is 83.54%, operating margin of -405.54%, and the pretax margin is -378.34%.
CorMedix Inc (CRMD) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of CorMedix Inc is 2.35%, while institutional ownership is 32.01%. The most recent insider transaction that took place on Oct 31 ’24, was worth 14,985. In this transaction EVP, Chief Commercial Officer of this company bought 1,500 shares at a rate of $9.99, taking the stock ownership to the 52,011 shares. Before that another transaction happened on Nov 14 ’24, when Company’s EVP sold 140,027 for $11.18, making the entire transaction worth $1,565,670. This insider now owns 45,397 shares in total.
CorMedix Inc (CRMD) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.95% per share during the next fiscal year.
CorMedix Inc (NASDAQ: CRMD) Trading Performance Indicators
Here are CorMedix Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.60. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 48.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit 0.12 in the next quarter and is forecasted to reach 0.50 in one year’s time.
Technical Analysis of CorMedix Inc (CRMD)
CorMedix Inc (NASDAQ: CRMD) saw its 5-day average volume 1.33 million, a negative change from its year-to-date volume of 1.48 million. As of the previous 9 days, the stock’s Stochastic %D was 1.68%. Additionally, its Average True Range was 0.71.
During the past 100 days, CorMedix Inc’s (CRMD) raw stochastic average was set at 51.99%, which indicates a significant increase from 2.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 65.31% in the past 14 days, which was lower than the 83.41% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.00, while its 200-day Moving Average is $7.39. Nevertheless, the first resistance level for the watch stands at $10.10 in the near term. At $10.33, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.49. If the price goes on to break the first support level at $9.71, it is likely to go to the next support level at $9.55. Assuming the price breaks the second support level, the third support level stands at $9.32.
CorMedix Inc (NASDAQ: CRMD) Key Stats
With a market capitalization of 598.28 million, the company has a total of 60,677K Shares Outstanding. Currently, annual sales are 0 K while annual income is -46,340 K. The company’s previous quarter sales were 11,460 K while its latest quarter income was -2,780 K.
